KALV – KalVista Pharmaceuticals Inc
KalVista Pharmaceuticals, Inc.KALV
$11.31Name : KalVista Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $562,034,880.00
EPSttm : -3.77
KalVista Pharmaceuticals, Inc.
$11.31
0.92%$0.105Float Short %
16.25
Margin Of Safety %
Put/Call OI Ratio
0.11
EPS Next Q Diff
EPS Last/This Y
-0.12
EPS This/Next Y
0.58
Price
11.31
Target Price
26.44
Analyst Recom
1
Performance Q
-5.24
Relative Volume
1.04
Beta
-0.03
Ticker: KALV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | KALV | 12.84 | 0.20 | 0.21 | 21325 |
| 2025-06-03 | KALV | 13.36 | 0.20 | 0.05 | 21517 |
| 2025-06-04 | KALV | 13.55 | 0.20 | 0.05 | 21502 |
| 2025-06-05 | KALV | 13.81 | 0.19 | 0.37 | 22247 |
| 2025-06-06 | KALV | 14.37 | 0.20 | 0.02 | 22500 |
| 2025-06-09 | KALV | 14.77 | 0.20 | 0.04 | 22503 |
| 2025-06-10 | KALV | 14.21 | 0.20 | 0.04 | 22731 |
| 2025-06-11 | KALV | 13.46 | 0.20 | 0.04 | 22861 |
| 2025-06-12 | KALV | 13.09 | 0.20 | 0.03 | 22877 |
| 2025-06-13 | KALV | 13.04 | 0.20 | 0.11 | 22992 |
| 2025-06-16 | KALV | 13.03 | 0.20 | 0.42 | 23119 |
| 2025-06-17 | KALV | 12.15 | 0.21 | 2.87 | 23652 |
| 2025-06-18 | KALV | 12.31 | 0.25 | 0.04 | 24540 |
| 2025-06-20 | KALV | 12.13 | 0.25 | 1.02 | 24600 |
| 2025-06-23 | KALV | 11.96 | 0.10 | 0.08 | 11329 |
| 2025-06-24 | KALV | 11.69 | 0.10 | 0.30 | 11843 |
| 2025-06-25 | KALV | 11.66 | 0.12 | 0.05 | 12175 |
| 2025-06-26 | KALV | 11.52 | 0.11 | 0.02 | 13387 |
| 2025-06-27 | KALV | 11.39 | 0.11 | 0.07 | 13124 |
| 2025-06-30 | KALV | 11.3 | 0.11 | 0.01 | 14656 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | KALV | 12.90 | 22.3 | - | -3.56 |
| 2025-06-03 | KALV | 13.35 | 22.3 | - | -3.56 |
| 2025-06-04 | KALV | 13.55 | 22.3 | - | -3.56 |
| 2025-06-05 | KALV | 13.80 | 22.3 | - | -3.56 |
| 2025-06-06 | KALV | 14.38 | 22.3 | - | -3.56 |
| 2025-06-09 | KALV | 14.76 | 22.3 | - | -3.56 |
| 2025-06-10 | KALV | 14.23 | 22.3 | - | -3.56 |
| 2025-06-11 | KALV | 13.49 | 22.3 | - | -3.56 |
| 2025-06-12 | KALV | 13.09 | 22.3 | - | -3.56 |
| 2025-06-13 | KALV | 12.94 | 22.3 | - | -3.56 |
| 2025-06-16 | KALV | 13.04 | 22.3 | - | -3.56 |
| 2025-06-17 | KALV | 12.17 | 22.3 | - | -3.56 |
| 2025-06-18 | KALV | 12.31 | 22.3 | - | -3.56 |
| 2025-06-20 | KALV | 12.15 | 22.3 | - | -3.56 |
| 2025-06-23 | KALV | 11.93 | 22.3 | - | -3.56 |
| 2025-06-24 | KALV | 11.72 | 22.3 | - | -3.56 |
| 2025-06-25 | KALV | 11.69 | 22.3 | - | -3.56 |
| 2025-06-26 | KALV | 11.51 | 22.3 | - | -3.56 |
| 2025-06-27 | KALV | 11.40 | 22.3 | - | -3.56 |
| 2025-06-30 | KALV | 11.31 | 22.3 | - | -3.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | KALV | 2.78 | -6.27 | 15.87 |
| 2025-06-03 | KALV | 2.78 | -6.27 | 15.87 |
| 2025-06-04 | KALV | 2.78 | -6.27 | 15.87 |
| 2025-06-05 | KALV | 2.78 | -6.27 | 15.87 |
| 2025-06-06 | KALV | 2.78 | -6.27 | 15.87 |
| 2025-06-09 | KALV | 2.78 | -6.37 | 15.87 |
| 2025-06-11 | KALV | 2.79 | -6.37 | 16.16 |
| 2025-06-12 | KALV | 2.79 | -6.37 | 16.16 |
| 2025-06-13 | KALV | 2.79 | -6.37 | 16.16 |
| 2025-06-16 | KALV | 2.79 | -6.37 | 16.16 |
| 2025-06-17 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-18 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-19 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-20 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-24 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-25 | KALV | 2.78 | -6.37 | 16.16 |
| 2025-06-26 | KALV | 2.78 | -6.37 | 16.25 |
| 2025-06-27 | KALV | 2.78 | -6.37 | 16.25 |
| 2025-06-30 | KALV | 2.78 | -6.35 | 16.25 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.92
Avg. EPS Est. Current Quarter
-0.83
Avg. EPS Est. Next Quarter
-0.92
Insider Transactions
2.78
Institutional Transactions
-6.35
Beta
-0.03
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
5
Growth Score
20
Sentiment Score
35
Actual DrawDown %
74.9
Max Drawdown 5-Year %
-90.1
Target Price
26.44
P/E
Forward P/E
PEG
P/S
P/B
3.86
P/Free Cash Flow
EPS
-3.73
Average EPS Est. Cur. Y
-3.56
EPS Next Y. (Est.)
-2.98
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.04
Return on Equity vs Sector %
-145
Return on Equity vs Industry %
-125.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.22
EBIT Estimation
KalVista Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 150
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.
stock quote shares KALV – KalVista Pharmaceuticals Inc Stock Price stock today
news today KALV – KalVista Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KALV – KalVista Pharmaceuticals Inc yahoo finance google finance
stock history KALV – KalVista Pharmaceuticals Inc invest stock market
stock prices KALV premarket after hours
ticker KALV fair value insiders trading